Krystal Biotech (KRYS) Inventory Average (2023 - 2026)

Krystal Biotech has reported Inventory Average for 4 years, with the latest figure at $44.1 million in Q2 2026.

• Inventory Average for Q2 2026 came in at $44.1 million, up 44.63% year-over-year; the trailing twelve-month figure through Jun 2026 was $44.1 million (up 44.63% YoY), and the FY2025 annual result was $33.5 million, up 99.99% from the prior year.
• Inventory Average grew to $44.1 million in Q2 2026, from $41.6 million in the prior quarter.
• Over five years, Inventory Average peaked at $44.1 million in Q2 2026 and troughed at $6.1 million in Q4 2023.
• A 4-year average of $25.7 million and a median of $28.2 million in 2025 frame the typical range for Inventory Average.
• The widest annual swing landed in 2024, when Inventory Average jumped 267.68%; it then soared 44.63% in 2026.
• A 4-year view of Inventory Average shows it stood at $6.1 million in 2023, then jumped by 267.68% to $22.5 million in 2024, then surged by 73.23% to $39.1 million in 2025, then grew by 12.92% to $44.1 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $44.1 million in Q2 2026, $41.6 million in Q1 2026, and $39.1 million in Q4 2025.